Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.53 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.53 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | GFER | P55789 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HTR2B | P41595 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5204359 | 0.82 | SLC6A4 (0.63) | F2PRSS1GRIN2BSLC6A4SLC6A3 | |
| SCHEMBL5377865 | 0.81 | GRIN2B (0.48) | F2PRSS1GRIN2BSLC6A4SLC6A3 | |
| SCHEMBL7134765 | 0.79 | GRIN2B (0.53) | F2PRSS1GRIN2BMAPTHTT | |
| SCHEMBL5378646 | 0.79 | MEN1 (0.52) | GRIN2BSLC6A4SLC6A3MAPTHTT | |
| SCHEMBL5374207 | 0.76 | GPR84 (0.52) | GRIN2BMAPTHTTGFERSMN1; SMN2 | |
| SCHEMBL5387265 | 0.73 | GPR84 (0.52) | GRIN2BMAPTHTTGFERSMN1; SMN2 | |
| SCHEMBL5377680 | 0.73 | CYP2C9 (0.45) | GRIN2BMAPTMAPK14CYP2C9CYP2C19 | |
| SCHEMBL7617666 | 0.73 | MAPT (0.55) | MAPTHTTGFERSMN1; SMN2MAPK14 | |
| SCHEMBL5377860 | 0.73 | GRIN2D (0.52) | GRIN2BMAPTHTTGFERSMN1; SMN2 | |
| SCHEMBL5383885 | 0.73 | GPR84 (0.51) | GRIN2BMAPTHTTGFERSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7189739-B2 | Compounds and methods to treat cardiac failure and other disorders | SCIOS, INC. (US) | 2007-03-13 | — | — | US | disclosed |
| EP-1080078-B1 | HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS | SCIOS INC (US) | 2006-02-01 | — | — | EP | disclosed |
| US-6589954-B1 | Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful | SCIOS, INC. | 2003-07-08 | — | — | US | disclosed |
| US-6340685-B1 | ANTIINFLAMMATORY AGENTS | SCIOS, INC. | 2002-01-22 | — | — | US | disclosed |
| EP-1080078-A1 | HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS | SCIOS INC. (US) | 2001-03-07 | — | — | EP | disclosed |
| WO-1999061426-A1 | HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS | SCIOS INC. (US) | 1999-12-02 | — | — | WO | disclosed |